Enzyme Induction

The metabolic clearance of a drug (victim) can be increased and its efficacy reduced, if it is co-administered with a second drug (perpetrator) that up-regulates (or induces) the enzyme responsible for the victim drug's metabolism. The increased clearance may comprise the therapeutic effectiveness or safety of the victim drug. As such, the FDA and other regulatory agencies recognize enzyme induction as a potential cause of drug-drug interactions. Sekisui XenoTech offers well-designed Cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) in vitro studies that meet or exceed the FDA and/or EMA's latest regulatory guidance for enzyme induction.

Sekisui XenoTech's Enzyme Induction group offers the following services that can be tailored to the specific needs of the client and/or the drug in question:
   

Enzyme Induction Automation and Analysis

  • Validated qRT-PCR methods
  • Tecan liquid handling systems or manual incubations available
  • Validated LC-MS/MS methods
  • High throughput Shimadzu autosamplers
  • Deuterated internal standards (all CYPs and most UGTs)
  • Automated data retrieval and processing
  • Comprehensive, publication-quality reports
  • Available as GLP or non-GLP
  Find the Services You Need  
How Can We Help You?
Or Call 1-877-588-7530
(+1.913.438.7450 If Outside North America)
Contact Us

Contact Us

Questions or inquiries? Use our contact form and we’ll reply as soon as possible.* indicates required field

Request A Quote
Request A Quote

Request A Quote

 Security code